The eye in systemic infection

Lancet

Volumn 364, Issue 9443, 2004, Pages 1439-1450

  Lynn, W A ^a   Lightman, Prof S ^a,b  

^a EALING HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CASPOFUNGIN; CIDOFOVIR; CORTICOSTEROID; ENDOTOXIN; ETHAMBUTOL; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; MINOCYCLINE; OFLOXACIN; OLIGONUCLEOTIDE; PENICILLIN G; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; SPIRAMYCIN; SULFONAMIDE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VALGANCICLOVIR; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CONFERENCE PAPER; CONGENITAL INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DRUG MEGADOSE; DRUG TOLERABILITY; ENDOPHTHALMITIS; EYE INFECTION; FUNGUS TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HERPES VIRUS INFECTION; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION CONTROL; INFECTION RISK; KERATITIS; LEPROSY; LIVER INJURY; MALARIA; MORBIDITY; MYCOSIS; NONHUMAN; ONCHOCERCIASIS; OPPORTUNISTIC INFECTION; OPTIC NERVE DISEASE; PARASITOSIS; PRIORITY JOURNAL; PROGNOSIS; RETINA ISCHEMIA; RICKETTSIOSIS; RISK ASSESSMENT; SIDE EFFECT; SYPHILIS; TOXOCARIASIS; TOXOPLASMOSIS; TREATMENT OUTCOME; TREATMENT PLANNING; TUBERCULOSIS; VIRUS INFECTION; VIRUS LATENCY; VISUAL IMPAIRMENT;

EID: 5644224318     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17228-0     Document Type: Conference Paper

References (150)

1. Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture- positive cases at a tertiary care center. Medicine (Baltimore). 82:2003;97-105
2. Rao NA. Acquired immunodeficiency syndrome and its ocular complications. Indian J Ophthalmol. 42:1994;51-63
3. Kochar DK, Shubhakaran, Kumawat BL, Thanvi I, Joshi A, Vyas SP. Ophthalmoscopic abnormalities in adults with falciparum malaria. QJM. 91:1998;845-852
4. Sekhar GC, Vance G, Otton S, Kumar SV, Stanley JN, Rao GN. Ocular manifestations of Hansen's disease. Doc Ophthalmol. 87:1994;211-221
5. Krishna R, Amuh D, Lowder CY, Gordon SM, Adal KA, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 14:2000;30-34
6. Arcieri ES, Jorge EF, de Abrea Ferreira L, et al. Bilateral endogenous endophthalmitis associated with infective endocarditis: case report. Braz J Infect Dis. 5:2001;356-359
7. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 101:1994;832-838
8. Lee SY, Chee SP. Group B Streptococcus endogenous endophthalmitis: case reports and review of the literature. Ophthalmology. 109:2002;1879-1886
9. Ang LP, Lee HM, Au Eong KG, Yap EY, Lim AT. Endogenous Klebsiella endophthalmitis. Eye. 14:2000;855-860
10. Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 107:2000;1483-1491
11. Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qiu H. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis: a retrospective 12-year study of 79 eyes of 46 patients. Retina. 21:2001;203-209
12. Uzun O, Ascioglu S, Anaissie EJ, Rex JH. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis. 32:2001;1713-1717
13. Weishaar PD, Flynn HW Jr, Murray TG, et al. Endogenous aspergillus endophthalmitis: clinical features and treatment outcomes. Ophthalmology. 105:1998;57-65
14. Feman SS, Nichols JC, Chung SM, Theobald TA. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 2002; 100: 67-70; discussion 70-71.
15. Tiribelli M, Zaja F, Fili C, et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol. 68:2002;314-317
16. Kontoyiannis DP, Bodey GP, Mantzoros CS. Fluconazole vs amphotericin B for the management of candidaemia in adults: a meta-analysis. Mycoses. 44:2001;125-135
17. Chen YC, Chang SC, Luh KT, Hsieh WC. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother. 52:2003;71-77
18. O'Day DM, Head WS, Robinson RD, Stern WH, Freeman JM. Intraocular penetration of systemically administered antifungal agents. Curr Eye Res. 4:1985;131-134
19. Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. 39:1990;877-916
20. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis. 12:1990;1147-1201
21. Smiddy WE. Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol. 9:1998;66-70
22. Laverdiere M, Hoban D, Restieri C, Habel F. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J Antimicrob Chemother. 50:2002;119-123
23. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA. 282:1999;677-686
24. Ni C, Papale JJ, Robinson NL, Wu BF. Uveal tuberculosis. Int Ophthalmol Clin. 22:1982;103-124
25. Rosen PH, Spalton DJ, Graham EM. Intraocular tuberculosis. Eye. 4:1990;486-492
26. Gopal L, Rao SK, Biswas J, Madhavan HN, Agarwal S. Tuberculous granuloma managed by full thickness eye wall resection. Am J Ophthalmol. 135:2003;93-94
27. Raina UK, Tuli D, Arora R, Mehta DK, Taneja M. Tubercular endophthalmitis simulating retinoblastoma. Am J Ophthalmol. 130:2000;843-845
28. Hoh HB, Kong VY, Jaais F. Tuberculous retinal vasculitis. Med J Malaysia. 53:1998;288-289
29. Bouza E, Merino P, Munoz P, Sanchez-Carrillo C, Yanez J, Cortes C. Ocular tuberculosis: a prospective study in a general hospital. Medicine (Baltimore). 76:1997;53-61
30. Rohatgi J, Dhaliwal U. Phlyctenular eye disease: a reappraisal. Jpn J Ophthalmol. 44:2000;146-150
31. Gupta A, Gupta V, Arora S, Dogra MR, Bambery P. PCR-positive tubercular retinal vasculitis: clinical characteristics and management. Retina. 21:2001;435-444
32. Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. 12:2001;433-441
33. Villanueva AV, Sahouri MJ, Ormerod LD, Puklin JE, Reyes MP. Posterior uveitis in patients with positive serology for syphilis. Clin Infect Dis. 30:2000;479-485
34. Jumper JM, Machemer R, Gallemore RP, Jaffe GJ. Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. Retina. 20:2000;190-194
35. Young S, Bom S, Lightman S. An unusual case of retinitis. Lancet. 355:2000;984
36. Kuo IC, Kapusta MA, Rao NA. Vitritis as the primary manifestation of ocular syphilis in patients with HIV infection. Am J Ophthalmol. 125:1998;306-311
37. van Voorst Vader PC. Syphilis management and treatment. Dermatol Clin 1998; 16: 699-711, xi.
38. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 4:2004;456-466
39. Khan T, Awan AA, Kazmi HS, Shah AA, Muhammad S, Muhammad S. Frequency of ocular complications of leprosy in institutionalized patients in NWFP Pakistan. J Ayub Med Coll Abbottabad. 14:2002;29-33
40. Courtright P, Daniel E, Sundarrao, et al. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev. 73:2002;225-238
41. Waddell KM, Saunderson PR. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Br J Ophthalmol. 79:1995;250-256
42. Comer JA, Paddock CD, Childs JE. Urban zoonoses caused by Bartonella, Coxiella, Ehrlichia, and Rickettsia species. Vector Borne Zoonotic Dis. 1:2001;91-118
43. Smith TW, Burton TC. The retinal manifestations of Rocky Mountain spotted fever. Am J Ophthalmol. 84:1977;259-262
44. Gerde LS, Kirchner DB. Conjunctival hemorrhage and Rocky Mountain spotted fever. South Med J. 75:1982;255
45. Cherubini TD, Spaeth GL. Anterior nongranulomatous uveitis associated with Rocky Mountain spotted fever. First report of a case. Arch Ophthalmol. 81:1969;363-365
46. Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Sakagami T. Branch retinal vein occlusion in the right eye and retinal hemorrhage in the left in a patient with classical Tsutsugamushi disease. Jpn J Ophthalmol. 45:2001;108-110
47. Kato T, Watanabe K, Katori M, Terada Y, Hayasaka S. Conjunctival injection, episcleral vessel dilation, and subconjunctival hemorrhage in patients with new tsutsugamushi disease. Jpn J Ophthalmol. 41:1997;196-199
48. Lee MS, Goslee TE, Lessell S. Ehrlichiosis optic neuritis. Am J Ophthalmol. 135:2003;412-413
49. Tabbara KF, al-Kassimi H. Ocular brucellosis. Br J Ophthalmol. 74:1990;249-250
50. Gungur K, Bekir NA, Namiduru M. Ocular complications associated with brucellosis in an endemic area. Eur J Ophthalmol. 12:2002;232-237
51. Avila MP, Jalkh AE, Feldman E, Trempe CL, Schepens CL. Manifestations of Whipple's disease in the posterior segment of the eye. Arch Ophthalmol. 102:1984;384-390
52. Karma A, Seppala I, Mikkila H, Kaakkola S, Viljanen M, Tarkkanen A. Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol. 119:1995;127-135
53. Mikkila HO, Seppala IJ, Viljanen MK, Peltomaa MP, Karma A. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology. 107:2000;581-587
54. Carithers HA. Oculoglandular disease of parinaud. A manifestation of cat-scratch disease. Am J Dis Child. 132:1978;1195-1200
55. Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol. 130:2000;340-349
56. Mancel E, Merien F, Pesenti L, Salino D, Angibaud G, Perolat P. Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol. 27:1999;380-386
57. Rathinam SR, Namperumalsamy P. Leptospirosis. Ocul Immunol Inflamm. 7:1999;109-118
58. Steinemann TL, Sheikholeslami MR, Brown HH, Bradsher RW. Oculoglandular tularemia. Arch Ophthalmol. 117:1999;132-133
59. Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 32:2000;1965-1966
60. Zakka KA, Foos RY, Brown WJ. Intraocular coccidioidomycosis. Surv Ophthalmol. 22:1978;313-321
61. Specht CS, Mitchell KT, Bauman AE, Gupta M. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome. Ophthalmology. 98:1991;1356-1359
62. Kestelyn P, Taelman H, Bogaerts J, et al. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 116:1993;721-727
63. Crump JR, Elner SG, Elner VM, Kauffman CA. Cryptococcal endophthalmitis: case report and review. Clin Infect Dis. 14:1992;1069-1073
64. Lee WH, Charles SJ. Acute retinal necrosis following chicken- pox in a healthy 4 year old patient. Br J Ophthalmol. 84:2000;667-668
65. Barondes MJ, Tellez F, Siegel A. Acute retinal necrosis after chickenpox in a healthy adult. Ann Ophthalmol. 24:1992;335-336
66. Walters G, James TE. Viral causes of the acute retinal necrosis syndrome. Curr Opin Ophthalmol. 12:2001;191-195
67. Nakanishi F, Takahashi H, Ohara K. Acute retinal necrosis following contralateral herpes zoster ophthalmicus. Jpn J Ophthalmol. 44:2000;561-564
68. Al-Abdulla NA, Rismondo V, Minkowski JS, Miller NR. Herpes zoster vasculitis presenting as giant cell arteritis with bilateral internuclear ophthalmoplegia. Am J Ophthalmol. 134:2002;912-914
69. Bayu S, Alemayehu W. Clinical profile of herpes zoster ophthalmicus in Ethiopians. Clin Infect Dis. 24:1997;1256-1260
70. Batisse D, Eliaszewicz M, Zazoun L, Baudrimont M, Pialoux G, Dupont B. Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS. 10:1996;55-60
71. Zambarakji HJ, Obi AA, Mitchell SM. Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocul Immunol Inflamm. 10:2002;41-46
72. Uninsky E, Jampol LM, Kaufman S, Naraqi S. Disseminated herpes simplex infection with retinitis in a renal allograft recipient. Ophthalmology. 90:1983;175-178
73. Maertzdorf J, Van der Lelij A, Baarsma GS, Osterhaus AD, Verjans GM. Herpes simplex virus type 1 (HSV-1)-induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol. 48:2000;936-939
74. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. BMJ. 5470:1965;1099-1102
75. Polic B, Hengel H, Krmpotic A, et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med. 188:1998;1047-1054
76. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med. 108:1988;585-594
77. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 115:1993;575-582
78. Salomon N, Perlman DC. Cytomegalovirus pneumonia. Semin Respir Infect. 14:1999;353-358
79. Group VS. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol. 133:2002;484-498
80. Martin DF, Dunn JP, Davis JL, et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol. 127:1999;329-339
81. Holland GN, Shuler JD. Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol. 110:1992;1435-1442
82. Lalezari J, Lindley J, Walmsley S, et al. A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis. J Acquir Immune Defic Syndr. 30:2002;392-400
83. Jabs DA, Martin BK, Forman MS, et al. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol. 135:2003;26-34
84. See RF, Rao NA. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am 2002; 15: 529-36, viii.
85. Behrens GM, Meyer D, Stoll M, Schmidt RE. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy. Immunobiology. 202:2000;186-193
86. Kramer M, Lynn W, Lightman S. HIV/AIDS and the eye. Hosp Med. 63:2003;421-424
87. Rosberger DF, Heinemann MH, Friedberg DN, Holland GN. Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol. 125:1998;301-305
88. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 4:1991;770-776
89. Brun SC, Jakobiec FA. Kaposi's sarcoma of the ocular adnexa. Int Ophthalmol Clin. 37:1997;25-38
90. Rivero ME, Kuppermann BD, Wiley CA, et al. Acquired immunodeficiency syndrome-related intraocular B-cell lymphoma. Arch Ophthalmol. 117:1999;616-622
91. Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea. 22:2003;1-4
92. Bedrosian RH. Neuroretinitis following measles. J Pediatr. 46:1955;329-331
93. De Laey JJ, Hanssens M, Colette P, Geerts L, Priem H. Subacute sclerosing panencephalitis: fundus changes and histopathologic correlations. Doc Ophthalmol. 56:(1-2):1983;11-21
94. Kayikcioglu O, Kir E, Soyler M, Guler C, Irkec M. Ocular findings in a measles epidemic among young adults. Ocul Immunol Inflamm. 8:2000;59-62
95. Khubchandani R, Rane T, Agarwal P, Nabi F, Patel P, Shetty AK. Bilateral neuroretinitis associated with mumps. Arch Neurol. 59:2002;1633-1636
96. Wolff SM. The ocular manifestations of congenital rubella. Trans Am Ophthalmol Soc. 70:1972;577-614
97. Vijayalakshmi P, Kakkar G, Samprathi A, Banushree R. Ocular manifestations of congenital rubella syndrome in a developing country. Indian J Ophthalmol. 50:2002;307-311
98. van Velden DJ, Meyer JD, Olivier J, Gear JH, McIntosh B. Rift Valley fever affecting humans in South Africa: a clinicopathological study. S Afr Med J. 51:1977;867-871
99. Bains HS, Jampol LM, Caughron MC, Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol. 121:2003;205-207
100. Haritoglou C, Scholz F, Bialasiewicz A, Klauss V. Ocular manifestation in dengue fever. Ophthalmologe. 97:2000;433-436
101. Gardner BP, Margolis TP, Mondino BJ. Conjunctival lymphocytic nodule associated with the Epstein-Barr virus. Am J Ophthalmol. 112:1991;567-571
102. Wong KW, D'Amico DJ, Hedges TR 3rd, Soong HK, Schooley RT, Kenyon KR. Ocular involvement associated with chronic Epstein-Barr virus disease. Arch Ophthalmol. 105:1987;788-792
103. Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol. 134:2002;190-195
104. Sarui H, Sano A, Maruyama T, Nakashima K, Takeda N, Yasuda K. Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease. Am J Med Sci. 324:2002;109-114
105. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA community-based uveitis study group. Am J Ophthalmol. 121:1996;35-46
106. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 321:2000;142-147
107. Hogan MJ, Kimura SJ, O'Connor GR. Ocular toxoplasmosis. Arch Ophthalmol. 72:1964;592-600
108. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 81:1969;481-493
109. Dutton GN, Hay J. Toxoplasmic retinochoroiditis - current concepts in pathogenesis. Trans Ophthalmol Soc UK. 103:1983;503-507
110. Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003; 110: 926-31; quiz 931-32.
111. Gilbert RE, See SE, Jones LV, Stanford MS. Antibiotics versus control for toxoplasma retinochoroiditis (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Chichester, UK: John Wiley & Sons, Ltd.
112. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 134:2002;34-40
113. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 109:2002;869-878
114. Bosch-Driessen EH, Rothova A. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol. 128:1999;421-425
115. Antsaklis A, Daskalakis G, Papantoniou N, Mentis A, Michalas S. Prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn. 22:2002;1107-1111
116. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 56:2001;296-305
117. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 110:2003;112-120
118. Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T. Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr. 22:2002;213-218
119. Maetz HM, Kleinstein RN, Federico D, Wayne J. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 156:1987;414
120. Smith RE, Ganley JP. Ophthalmic survey of a community. 1. Abnormalities of the ocular fundus. Am J Ophthalmol. 74:1972;1126-1130
121. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 114:1992;136-144
122. Richards FO Jr, Kovacs JA, Luft BJ. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis. 21:(suppl 1):1995;S49-S56
123. Schantz PM, Meyer D, Glickman LT. Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am J Trop Med Hyg. 28:1979;24-28
124. Brown DH. Ocular Toxocara canis II. Clinical review. J Paediatr Ophthalmol. 7:1970;182-191
125. Sharkey JA, McKay PS. Ocular toxocariasis in a patient with repeatedly negative ELISA titre to Toxocara canis. Br J Ophthalmol. 77:1993;253-254
126. Biglan AW, Glickman LT, Lobes LA Jr. Serum and vitreous Toxocara antibody in nematode endophthalmitis. Am J Ophthalmol. 88:1979;898-901
127. Wilkinson CP, Welch RB. Intraocular toxocara. Am J Ophthalmol. 71:1971;921-930
128. Sabrosa NA, de Souza EC. Nematode infections of the eye: toxocariasis and diffuse unilateral subacute neuroretinitis. Curr Opin Ophthalmol. 12:2001;450-454
129. Margo CE, Katz NN, Wertz FD, Dorwart RH. Sclerosing endophthalmitis in children: computed tomography with histopathologic correlation. J Pediatr Ophthalmol Strabismus. 20:1983;180-184
130. Kaimbo Wa Kaimbo D, Missotten L. Severe subconjunctival haemorrhage associated with malaria. Bull Soc Belge Ophtalmol. 271:1999;51-53
131. Lewallen S, Harding SP, Ajewole J, et al. A review of the spectrum of clinical ocular fundus findings in P falciparum malaria in African children with a proposed classification and grading system. Trans R Soc Trop Med Hyg. 93:1999;619-622
132. Kochar DK, Shubhakaran, Kumawat BL, Vyas SP. Prognostic significance of eye changes in cerebral malaria. J Assoc Physicians India. 48:2000;473-477
133. Lewallen S, Bakker H, Taylor TE, Wills BA, Courtright P, Molyneux ME. Retinal findings predictive of outcome in cerebral malaria. Trans R Soc Trop Med Hyg. 90:1996;144-146
134. Lewallen S, White VA, Whitten RO, et al. Clinical-histopathological correlation of the abnormal retinal vessels in cerebral malaria. Arch Ophthalmol. 118:2000;924-928
135. Lewallen S, Taylor TE, Molyneux ME, Semba RD, Wills BA, Courtright P. Association between measures of vitamin A and the ocular fundus findings in cerebral malaria. Arch Ophthalmol. 116:1998;293-296
136. Hero M, Harding SP, Riva CE, Winstanley PA, Peshu N, Marsh K. Photographic and angiographic characterization of the retina of Kenyan children with severe malaria. Arch Ophthalmol. 115:1997;997-1003
137. Umeh RE. The causes and profile of visual loss in an onchocerciasis- endemic forest-savanna zone in Nigeria. Ophthalmic Epidemiol. 6:1999;303-315
138. Hall LR, Pearlman E. Pathogenesis of onchocercal keratitis (River blindness). Clin Microbiol Rev. 12:1999;445-453
139. Schwartz EC, Huss R, Hopkins A, et al. Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic. Br J Ophthalmol. 81:1997;443-447
140. Kayembe DL, Kasonga DL, Kayembe PK, Mwanza JC, Boussinesq M. Profile of eye lesions and vision loss: a cross-sectional study in Lusambo, a forest-savanna area hyperendemic for onchocerciasis in the Democratic Republic of Congo. Trop Med Int Health. 8:2003;83-89
141. Chippaux JP, Boussinesq M, Fobi G, et al. Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses. Ophthalmic Epidemiol. 6:1999;229-246
142. Semba RD, Murphy RP, Newland HS, Awadzi K, Greene BM, Taylor HR. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology. 97:1990;1334-1341
143. Ejere H, Schwartz E, Wormald R. Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst Rev. 1:2001;CD002219
144. Sabrosa NA, Zajdenweber M. Nematode infections of the eye: toxocariasis, onchocerciasis, diffuse unilateral subacute neuroretinitis, and cysticercosis. Ophthalmol Clin North Am. 15:2002;351-356
145. Betharia SM, Pushker N, Sharma V, Avinash M, Kashyap S. Disseminated hydatid disease involving orbit, spleen, lung, and liver. Ophthalmologica. 216:2002;300-304
146. Bialasiewicz AA, Hassenstein A, Schaudig U. Subretinal granuloma, retinal vasculitis and keratouveitis with secondary open-angle glaucoma in schistosomiasis. Ophthalmologe. 98:2001;972-975
147. Workman DM, McNab AA. Loa Loa disease. Aust N Z J Ophthalmol. 18:1990;357-358
148. Cohen J, Armstrong D, eds. Infectious diseases, 1 st edn. London: Mosby, 1999.
149. Mandell GL, Bartlett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and practice of infectious diseases, 5th edn. London: Churchill Livingstone, 2000.
150. Pepose JS, Holland GN, Wilhemus KR, eds. Ocular infection and immunity. London: Mosby, 1996.